188 related articles for article (PubMed ID: 26291715)
41. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
[TBL] [Abstract][Full Text] [Related]
42. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
[TBL] [Abstract][Full Text] [Related]
43. Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity.
Qiao WB; Zhao YH; Zhao YB; Wang RZ
World J Gastroenterol; 2005 May; 11(17):2626-9. PubMed ID: 15849822
[TBL] [Abstract][Full Text] [Related]
44. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Forsythe K; Blacksburg S; Stone N; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
[TBL] [Abstract][Full Text] [Related]
45. Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma.
Liang SX; Zhu XD; Lu HJ; Pan CY; Li FX; Huang QF; Wang AY; Chen L; Fu XL; Jiang GL
Cancer; 2005 May; 103(10):2181-8. PubMed ID: 15812834
[TBL] [Abstract][Full Text] [Related]
46. IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer.
Trip AK; Nijkamp J; van Tinteren H; Cats A; Boot H; Jansen EP; Verheij M
Radiother Oncol; 2014 Aug; 112(2):289-94. PubMed ID: 25241995
[TBL] [Abstract][Full Text] [Related]
47. Hepatic dysfunction after radiotherapy for primary gastric lymphoma.
Tanaka H; Hayashi S; Ohtakara K; Hoshi H
J Radiat Res; 2013 Jan; 54(1):92-7. PubMed ID: 23283868
[TBL] [Abstract][Full Text] [Related]
48. Dose-dependent changes in renal (1)H-/(23)Na MRI after adjuvant radiochemotherapy for gastric cancer.
Haneder S; Budjan JM; Schoenberg SO; Konstandin S; Schad LR; Hofheinz RD; Gramlich V; Wenz F; Lohr F; Boda-Heggemann J
Strahlenther Onkol; 2015 Apr; 191(4):356-64. PubMed ID: 25445156
[TBL] [Abstract][Full Text] [Related]
49. Cumulative dose of radiation therapy of hepatocellular carcinoma patients and its deterministic relation to radiation-induced liver disease.
Huang P; Yu G; Kapp DS; Bian XF; Ma CS; Li HS; Chen JH; Liang YQ; Zhang Y; Qin SH; Xie YQ; Yang Y; Yin Y; Xing L; Li DW
Med Dosim; 2018 Autumn; 43(3):258-266. PubMed ID: 29198389
[TBL] [Abstract][Full Text] [Related]
50. [Assessment of radiation-induced liver injury with computed tomography].
Zhu XX; Chen LH; Wu DH; Chen YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):109-12. PubMed ID: 17259163
[TBL] [Abstract][Full Text] [Related]
51. A Radiation-Induced Hippocampal Vascular Injury Surrogate Marker Predicts Late Neurocognitive Dysfunction.
Farjam R; Pramanik P; Aryal MP; Srinivasan A; Chapman CH; Tsien CI; Lawrence TS; Cao Y
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):908-15. PubMed ID: 26530761
[TBL] [Abstract][Full Text] [Related]
52. Radiation-Induced Liver Toxicity.
Munoz-Schuffenegger P; Ng S; Dawson LA
Semin Radiat Oncol; 2017 Oct; 27(4):350-357. PubMed ID: 28865518
[TBL] [Abstract][Full Text] [Related]
53. Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma.
Dreher C; Høyer KI; Fode MM; Habermehl D; Combs SE; Høyer M
Acta Oncol; 2016 Jul; 55(7):886-91. PubMed ID: 26878669
[TBL] [Abstract][Full Text] [Related]
54. Analysis of radiation-induced liver disease using the Lyman NTCP model.
Dawson LA; Normolle D; Balter JM; McGinn CJ; Lawrence TS; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):810-21. PubMed ID: 12095546
[TBL] [Abstract][Full Text] [Related]
55. Clinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma.
Huang Y; Chen SW; Fan CC; Ting LL; Kuo CC; Chiou JF
Radiat Oncol; 2016 Jul; 11(1):89. PubMed ID: 27369241
[TBL] [Abstract][Full Text] [Related]
56. Kidney-sparing radiotherapy by multiple-field three-dimensional technique in the postoperative management of patients with gastric cancer: comparison with standard two-field conformal technique.
Marcenaro M; Foppiano F; Durzu S; Barra S; Corvò R
Tumori; 2006; 92(1):34-40. PubMed ID: 16683382
[TBL] [Abstract][Full Text] [Related]
57. Liver function tests profile in cancer patients on cytotoxic chemotherapy: a preliminary report.
Akuyam SA; Uchenna OK; Adamu A; Aliyu IS; Mai A; Dawotola DA; Adewuyi SA
Niger Postgrad Med J; 2011 Mar; 18(1):34-3. PubMed ID: 21445111
[TBL] [Abstract][Full Text] [Related]
58. Is pectus excavatum a risk factor for radiation-induced lung disease in patients undergoing radiation therapy following breast-conserving surgery?
Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Hata M; Sakurai K; Okada M
Thorac Cancer; 2019 Feb; 10(2):203-208. PubMed ID: 30561105
[TBL] [Abstract][Full Text] [Related]
59. Clinical outcome of palliative radiotherapy for locally advanced symptomatic gastric cancer in the modern era.
Tey J; Choo BA; Leong CN; Loy EY; Wong LC; Lim K; Lu JJ; Koh WY
Medicine (Baltimore); 2014 Nov; 93(22):e118. PubMed ID: 25396330
[TBL] [Abstract][Full Text] [Related]
60. The prediction of radiation-induced liver dysfunction using a local dose and regional venous perfusion model.
Cao Y; Platt JF; Francis IR; Balter JM; Pan C; Normolle D; Ben-Josef E; Haken RK; Lawrence TS
Med Phys; 2007 Feb; 34(2):604-12. PubMed ID: 17388178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
